# Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate

> **NCT03698721** · — · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 365 (estimated)

## Conditions studied

- Spina Bifida
- Urothelial Neoplasm
- Bladder, Neurogenic
- Bladder Exstrophy
- Hypospadias

## Interventions

- **PROCEDURE:** Transurethral Resection of Prostate

## Key facts

- **NCT ID:** NCT03698721
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2018-10
- **Primary completion:** 2024-10
- **Final completion:** 2026-10
- **Target enrollment:** 365 (ESTIMATED)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03698721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03698721, "Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03698721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*